Initial Treatment for Gout Flare
The recommended first-line options for acute gout flares are colchicine (within 12 hours of flare onset) at a loading dose of 1 mg followed 1 hour later by 0.5 mg on day 1, NSAIDs, or oral corticosteroids (30-35 mg/day of equivalent prednisolone for 3-5 days). 1
First-Line Treatment Options
Colchicine
- Dosing: 1.2 mg (two tablets) at the first sign of flare followed by 0.6 mg (one tablet) one hour later 2
- Timing: Most effective when given within 12 hours of symptom onset 1, 3
- Contraindications:
NSAIDs
- Full FDA-approved dose until the gout attack completely resolves 1
- Options include naproxen, indomethacin, or sulindac 1
- Should be used with a proton pump inhibitor if appropriate 1
- Contraindicated in patients with severe renal impairment or significant cardiovascular disease 3
Oral Corticosteroids
- Dosing: Prednisone/prednisolone 30-35 mg daily for 3-5 days 1, 3
- Options for administration:
- Particularly useful in patients with contraindications to colchicine or NSAIDs 3
Patient-Specific Considerations
Renal Function
- Normal renal function: Any first-line option is appropriate
- Severe renal impairment: Avoid colchicine and NSAIDs; use oral corticosteroids 1, 3
- For patients with moderate renal impairment using colchicine, dose should be reduced 2
Cardiovascular Disease
- Avoid NSAIDs
- Use colchicine (if renal function is normal) or oral corticosteroids 3
Diabetes
- Monitor for hyperglycemia when using corticosteroids 3
Patients Already on Prophylactic Colchicine
- Use prednisone rather than increasing colchicine dose 3
Treatment Timing and Duration
- Treat as early as possible - ideally within 24 hours of symptom onset 1
- The "pill in the pocket" approach is recommended to allow patients to self-medicate at the first warning symptoms 1, 3
- Continue treatment until the flare completely resolves 3
Combination Therapy
For severe, multiarticular flares, consider:
- Colchicine plus an NSAID
- Colchicine plus corticosteroids 1, 3
- Intra-articular corticosteroid injection may be added for specific affected joints 3
Second-Line Options
If first-line agents are contraindicated, not tolerated, or ineffective:
- IL-1 inhibitors (e.g., anakinra, canakinumab) 1
- Intra-articular corticosteroid injection 1
- Intramuscular corticosteroids: Triamcinolone acetonide 60 mg 1
Common Pitfalls to Avoid
- Delayed treatment: Efficacy significantly decreases when treatment is initiated beyond 12-36 hours of symptom onset 3
- Underdosing: May lead to incomplete resolution of symptoms 3
- Not considering comorbidities: Failing to adjust therapy based on renal function, cardiovascular disease, or diabetes can lead to adverse outcomes 3
- Interrupting urate-lowering therapy: Should not be stopped during an acute gout attack 1
- Neglecting prophylaxis: When initiating urate-lowering therapy, prophylaxis should be continued for 3-6 months 1, 3
Remember that early treatment is crucial for optimal efficacy. The choice between colchicine, NSAIDs, and corticosteroids should be based on patient comorbidities, timing of treatment initiation, and previous experience with these medications.